Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals

By Kappelhoff Bregt S.  

Clinical Pharmacokinetics, Vol. 44, Iss. 8, 2005-01 ,pp. : 849-861

Adis International

Access to resources Recommend Favorite

Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients

By Sriwiriyajan Somchai   Mahatthanatrakul Werawath   Ridtitid Wibool   Jaruratanasirikul Sutep  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 5, 2007-05 ,pp. : 479-483

Springer Publishing Company

Access to resources Recommend Favorite

Population Pharmacokinetics of Delavirdine and N -Delavirdine in HIV-Infected Individuals

By Patrick F. Smith   Robert DiCenzo  

Clinical Pharmacokinetics, Vol. 44, Iss. 1, 2005-01 ,pp. : 99-109

Adis International

Access to resources Recommend Favorite

Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients

By Elens Laure   Vandercam Bernard   Yombi Jean-Cyr   Lison Dominique   Wallemacq Pierre   Haufroid Vincent  

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1223-1234

Future Medicine

Access to resources Recommend Favorite

Low Nevirapine Plasma Concentrations Predict Virological Failure in an Unselected HIV-1-Infected Population

By de Vries-Sluijs T.E.M.S.  

Clinical Pharmacokinetics, Vol. 42, Iss. 6, 2003-01 ,pp. : 599-605

Adis International

Access to resources Recommend Favorite